Type of Study:
Contraception

Study Length:
24 months

Target Age/Sex:
35 years or younger female subjects

Benefits:
Participants will receive at no cost: Study medication and study related procedures. Subject may also receive a stipend for time/travel related to the study.

Link: ClinicalTrials.gov

Staus: Enrolling

Description:

A Study to Assess Contraceptive Efficacy and Safety of Etonogestrel (ENG) Implant (Nexplanon) Beyond 3 Years of Use.

To learn more, fill out the form or call 208-557-2991 or 208-557-2924.

Enroll Now

Enroll Now